CRP and myeloid sarcoma: Other data concluded that CRP values were not associated with MS risk, and a systematic review toward the topic demonstrated that results regarding CRP were inconsistent, and the current literature does not favor the clinical utility of CRP as a diagnostic or prognostic biomarker in MS cases [756,757,758].